Jul 18, 2023
7:5
For every 5 shares held, investors received 7. The price per share adjusted from $29.02 to $20.73.
The split itself did not change the total investment value.
CABIO Biotech (Wuhan) Co. Ltd. Class A (SSE:688089) operates in the Chemicals: specialty industry.
CABIO Biotech (Wuhan) Co. Ltd. Class A company overviewCABIO Biotech (Wuhan) Co. Ltd. Class A's most recent stock split was on July 18, 2023. It was a 7-for-5 forward split, so shareholders received 7 shares for every 5 they held.
CABIO Biotech (Wuhan) Co. Ltd. Class A has split its stock once. This history records one forward split, on July 18, 2023.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In CABIO Biotech (Wuhan) Co. Ltd. Class A's 7-for-5 split on July 18, 2023, every 5 shares became 7 shares.
CABIO Biotech (Wuhan) Co. Ltd. Class A has not announced a new split in our records. Its most recent split was on July 18, 2023, 3 years ago. Companies announce splits in advance, and any new SSE:688089 split will appear on this page.
Already premium?